Prelude Therapeutics PRLD
NASDAQ PRLD
$3.96 +0.05 (+1.28%)
At close: Sep 29, 2026 · 4:00 PM EDT

Prelude Therapeutics (PRLD) Operating Expenses (2019 - 2026)

Updated

Prelude Therapeutics' Operating Expenses was $21.16 million in Q2 2026, down 34.3% from $32.19 million a year earlier but up 12.8% from the prior quarter.

Analysis

Prelude Therapeutics (PRLD) Operating Expenses (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Prelude Therapeutics' Operating Expenses was $89.82 million through Jun 30, 2026, down 36.7% year-over-year; for FY2025, it came in at $116.71 million, down 20.5% from FY2024.

  • Operating Expenses shows a five-year compound annual growth rate of 14.7% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $146.71 million in FY2024 (+10.9%), $132.28 million in FY2023 (+7.1%), $123.54 million in FY2022 (+8.6%) and $113.74 million in FY2021 (+93.5%).
  • Quarterly Operating Expenses has moved between $18.76 million (Q1 2026) and $37.83 million (Q4 2024) over five years.
  • Compared with a year earlier, Operating Expenses has declined for five straight quarters, with an average decline of 18.3% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q3 2021 (growth of 70.0%); the worst was Q1 2026 (a decline of 45.8%).
  • Per Business Quant data, PRLD's Operating Expenses in the three quarters before Q2 2026 was $18.76 million (Q1 2026), $22.99 million (Q4 2025) and $26.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Prelude Therapeutics 312.03 Mn -285.27 Mn - 21.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.16 Mn
Mar 31, 2026 18.76 Mn
Dec 31, 2025 22.99 Mn
Sep 30, 2025 26.92 Mn
Jun 30, 2025 32.19 Mn
Mar 31, 2025 34.61 Mn
Dec 31, 2024 37.83 Mn
Sep 30, 2024 37.38 Mn
Jun 30, 2024 37.16 Mn
Mar 31, 2024 34.34 Mn
Dec 31, 2023 37.38 Mn
Sep 30, 2023 33.39 Mn
Jun 30, 2023 32.40 Mn
Mar 31, 2023 29.12 Mn
Dec 31, 2022 33.39 Mn
Sep 30, 2022 30.41 Mn
Jun 30, 2022 29.46 Mn
Mar 31, 2022 30.29 Mn
Dec 31, 2021 33.01 Mn
Sep 30, 2021 30.84 Mn
API Access

Prelude Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=PRLD&period=max&api_key=YOUR_API_KEY